drugset / Trial / NCT00209794
IPTi in Mozambican Infants for Malaria Prevention
RandomizedParallel-groupDouble-blindPrevention
Summary
To evaluate if intermittent preventive treatment in infants (IPTi) consisting of SP \[Fansidar\] given through the EPI scheme alongside routine immunisations at 3, 4 and 9 months of age reduces de incidence of clinical malaria up to 12 months of age
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pyrimethamine | Small molecule | 1.25 mg/kg | — |
| Subject | sulfadoxine | Small molecule | 25 mg/kg | — |